$21.39
0.090.45%
At close: -
$20.78
-0.61-2.87%
After Hours: Dec 24, 1:51 PM EDT
Comments
Loading...
Latest news for Tourmaline Bio (NASDAQ:TRML) Stock
Tourmaline Bio Stock (NASDAQ: TRML)
Categories: All
Wednesday, December 11, 2024
Tuesday, December 10, 2024
Friday, December 06, 2024
Monday, November 11, 2024
Thursday, November 07, 2024
Monday, August 12, 2024
Thursday, August 08, 2024
Friday, August 02, 2024
Thursday, June 27, 2024
Tuesday, May 14, 2024
Monday, May 13, 2024
Monday, March 25, 2024
Thursday, March 21, 2024
- Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Dow Jumps 200 Points; US Weekly Jobless Claims Fall
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Five Below Posts Q4 Results, Joins LexinFintech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Wednesday, March 20, 2024
Tuesday, March 19, 2024
Thursday, January 25, 2024
Wednesday, January 24, 2024
Monday, January 08, 2024
Wednesday, January 03, 2024
Friday, December 22, 2023
Friday, December 15, 2023
Tuesday, November 21, 2023
Friday, November 17, 2023
Tuesday, October 31, 2023
Monday, October 30, 2023
Friday, October 27, 2023
Wednesday, October 25, 2023
Tuesday, October 24, 2023
- Chief Medical Officer at Tourmaline Bio Acquires Company Stock Options Worth 217,426 Shares
- Tourmaline Bio Chief Regulatory Officer Awarded $1.36M Worth of Stock Options
- Tourmaline Bio Chief Technology Officer Awarded $1.17M Worth of Stock Options
- Tourmaline Bio Director Awarded $478K Worth of Stock Options
- Board Member at Tourmaline Bio Exercises Options Worth $205K
- CBO at Tourmaline Bio Acquires Company Stock Options Worth 171,765 Shares
- CEO at Tourmaline Bio Acquires Company Stock Options Worth 783,001 Shares